9th Annual Biomarkers Congress
Second Annual HCV DRUG DISCOVERY
HILTON SAN DIEGO RESORT
1775 East Mission Bay Drive
San Diego, CA 92109
http://www.healthtech.com
Second Annual HCV DRUG DISCOVERY
Cambridge Healthtech Institute 
HILTON SAN DIEGO RESORT

Schedule of Presentations:

Monday, April 6, 2009
07:00:00 Registration and Morning Coffee
08:00:00 Chairperson’s Opening Remarks Robert Ralston
08:10:00 Opening Keynote Presentation John G. McHutchison
08:50:00 Discovery of Telaprevir, a Potent HCV Protease Inhibitor Anne-Laure Grillot
09:20:00 Rational Design of Hepatitis C Virus NS3 Protease Inhibitors Atul Agarwal
09:50:00 Networking Coffee Break
10:15:00 Update on Boceprevir and other HCV Protease Inhbitors Robert Ralston
10:45:00 Pharmacokinetics and Pharmacodynamics of Taribavirin Gordon Loewen
11:15:00 Sponsored Presentation (Opportunity Available)
11:30:00 Panel Session on Combining Therapies John G. McHutchison
12:00:00 Luncheon Presentation (Opportunity Available) or Lunch on your own
13:25:00 Chairperson’s Remarks Dave Smith
14:00:00 Nucleoside Approach to Inhibitors for HCV Polymerase Michael J. Sofia
14:30:00 Identifi cation of Potent, Orally Bioavailable Non-Nucleoside HCV RNA Polymerase Inhibitors Frank Ruebsam
15:00:00 Sponsored Presentation (Opportunity Available)
15:15:00 Networking Refreshment Break in the Exhibit Hall
16:00:00 Small Molecule Approaches to NS4B and Other Novel Non-Structural Protein Targets Jeffrey S. Glenn
16:30:00 Current Progress in Developing HCV Entry Inhibitors Flossie Wong-Staal
17:00:00 HCV NS3 Helicase Inhibitors Anna Boguszewska-Chachulska
17:30:00 Reception in the Exhibit Hall
18:30:00 End of Day
Tuesday, April 7, 2009
07:50:00 Check-In
07:55:00 Continental Breakfast Break - Out Discussions with the Experts
08:00:00 Table 1: The Role of Immunotherapy for HCV infection Israel Rios
08:05:00 Table 2: Beyond interferon Jeffrey S. Glenn
08:10:00 Table 3: Are there good tissue culture systems for modeling HCV infection? Martina Buck
09:00:00 Chairperson’s Remarks James Appleman
09:05:00 Nitazoxanide for the Treatment of Chronic Hepatitis C Emmet B. Keeffe
09:35:00 Pharmacology of the Debio 025: A Potent Inhibitor of the Hepatitis C Virus Grégoire Vuagniaux
10:05:00 Sponsored Presentation (Opportunity Available)
10:20:00 Networking Coffee Break in the Exhibit Hall
11:00:00 Agonists of Innate Immune Receptors as Anti-HCV Agents Howard B. Cottam
11:30:00 Preclinical Characterization of SCY-635, a Non- Immunosuppressive Analog of Cyclosporine zhuhui Huang
12:00:00 End of Conference
12:35:00 Annoucements
12:35:00 Breakout Discussions
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.